Variant report
Variant | esv3464623 |
---|---|
Chromosome Location | chr4:172988573-172992958 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:172988137..172989930-chr4:172993221..172995055,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs567049806 | chr4:172988576-172988577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs182286046 | chr4:172988577-172988578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs187706238 | chr4:172988584-172988585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs386682113 | chr4:172988597-172988598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs1566944 | chr4:172988599-172988600 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs566389145 | chr4:172988622-172988623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs367980021 | chr4:172988640-172988641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs369669164 | chr4:172988656-172988657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs571886166 | chr4:172988724-172988725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs541148818 | chr4:172988768-172988769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192364923 | chr4:172988839-172988840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs7655005 | chr4:172988860-172988861 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs550102961 | chr4:172988874-172988875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs563531092 | chr4:172988879-172988880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs185774758 | chr4:172988889-172988890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs552582539 | chr4:172988973-172988974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs113613821 | chr4:172988990-172988991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs141262887 | chr4:172989152-172989153 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535193137 | chr4:172989171-172989172 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs142765383 | chr4:172989191-172989192 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs145356503 | chr4:172989192-172989193 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs113003786 | chr4:172989194-172989195 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs145761017 | chr4:172989206-172989207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs547522206 | chr4:172989294-172989295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs567320784 | chr4:172989307-172989308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs113833764 | chr4:172989375-172989376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs536347912 | chr4:172989389-172989390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs150988848 | chr4:172989515-172989516 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs575931861 | chr4:172989533-172989534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs538950698 | chr4:172989545-172989546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs1394858 | chr4:172989546-172989547 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs571926883 | chr4:172989569-172989570 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs1394857 | chr4:172989620-172989621 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs74421380 | chr4:172989696-172989697 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs7661357 | chr4:172989728-172989729 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs541581737 | chr4:172989800-172989801 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs574639939 | chr4:172989804-172989805 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs140863776 | chr4:172989819-172989820 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs13133832 | chr4:172989984-172989985 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs111457328 | chr4:172990055-172990056 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs373530113 | chr4:172990196-172990197 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs546500136 | chr4:172990250-172990251 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs539995687 | chr4:172990275-172990276 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs150170150 | chr4:172990328-172990329 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs560044897 | chr4:172990517-172990518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs528372225 | chr4:172990520-172990521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs138175318 | chr4:172990528-172990529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs533394219 | chr4:172990542-172990543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs376064645 | chr4:172990547-172990548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs568658630 | chr4:172990555-172990556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Schizophrenia | 23813976 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 22127048 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Prostate cancer | 22341455 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:172985400-172989200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
2 | chr4:172985800-172989000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
3 | chr4:172989000-172990400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr4:172989200-172989600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr4:172989400-172990400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr4:172989600-172992600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
7 | chr4:172990400-172992400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
8 | chr4:172992400-172995200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr4:172992600-172993200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |